Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson’s disease
Cell Stem Cell · 2025-09 · 32 (9) · 1346-1355.e3
DOI: 10.1016/j.stem.2025.07.012 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Cell Stem Cell, 2025-09. Verfasst von Asuka Morizane und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan; Center for Clini…. Hauptthemen laut MEDLINE: Parkinson Disease, Induced Pluripotent Stem Cells, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan; Center for Clinical Research and Innovation, Kobe City Medical Center General Hospital…
- Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
- Department of Hematology/Oncology, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan.
- Department of Surgery, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan.
- Department of Neurology, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan.
- Departmnt of Neurosurgery, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan.
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Morizane, A., Yamasaki, E., Shindo, T., Anazawa, T., Sawamoto, N., Shima, A., Yamakado, H., Nakanishi, E., Sawamura, M., Taruno, Y., Doi, D., Kikuchi, T., Kawasaki, Y., Saito, M. K., Kikuchi, T., Arakawa, Y., Miyamoto, S., Nakamoto, Y., Takahashi, R., & Takahashi, J. (2025). Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson’s disease. Cell Stem Cell, 32(9), 1346-1355.e3. https://doi.org/10.1016/j.stem.2025.07.012
Vancouver
Morizane A, Yamasaki E, Shindo T, Anazawa T, Sawamoto N, Shima A, et al. Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson’s disease. Cell Stem Cell. 2025;32(9):1346-1355.e3. doi:10.1016/j.stem.2025.07.012
BibTeX
@article{Morizane2025,
author = {Morizane, Asuka and Yamasaki, Emi and Shindo, Takero and Anazawa, Takayuki and Sawamoto, Nobukatsu and Shima, Atsushi and Yamakado, Hodaka and Nakanishi, Etsuro and Sawamura, Masanori and Taruno, Yosuke and Doi, Daisuke and Kikuchi, Tetsuhiro and Kawasaki, Yuri and Saito, Megumu K and Kikuchi, Takayuki and Arakawa, Yoshiki and Miyamoto, Susumu and Nakamoto, Yuji and Takahashi, Ryosuke and Takahashi, Jun},
title = {Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson’s disease},
journal = {Cell Stem Cell},
year = {2025},
volume = {32},
number = {9},
pages = {1346--1355.e3},
doi = {10.1016/j.stem.2025.07.012}
}
EUVIMED